TWST
NASDAQTwist Bioscience Corporation
News · 26 weeks99+725%
2026-03-012026-08-23
Mix5790d
- Insider35(61%)
- SEC Filings9(16%)
- Other7(12%)
- Analyst2(4%)
- Earnings2(4%)
- Offering2(4%)
Latest news
25 items- INSIDEROfficer Cho Dennis sold $222,227 worth of shares (1,598 units at $139.07), decreasing direct ownership by 2% to 74,063 units (SEC Form 4) to satisfy withholding tax4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERPresident and COO Finn Patrick John sold $562,661 worth of shares (4,046 units at $139.07), decreasing direct ownership by 2% to 210,802 units (SEC Form 4) (tax withholding)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERChief Accounting Officer Werner Robert F. sold $213,255 worth of shares (1,523 units at $140.02), decreasing direct ownership by 3% to 44,637 units (SEC Form 4) (withholding tax)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERChief Financial Officer Laponis Adam sold $273,265 worth of shares (1,965 units at $139.07), decreasing direct ownership by 2% to 108,633 units (SEC Form 4) to satisfy tax liability4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERChief Executive Officer Leproust Emily M. sold $923,259 worth of shares (6,639 units at $139.07), decreasing direct ownership by 0.81% to 812,299 units (SEC Form 4) to satisfy tax liability4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERSVP of Human Resources Green Paula sold $189,130 worth of shares (1,360 units at $139.07), decreasing direct ownership by 1% to 117,921 units (SEC Form 4) (tax withholding)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDEROfficer Cho Dennis sold $1,843,099 worth of shares (14,205 units at $129.75) as part of a pre-agreed trading plan, decreasing direct ownership by 16% to 75,661 units (SEC Form 4)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERPresident and COO Finn Patrick John exercised 23,355 shares at a strike of $67.85 and sold $9,217,607 worth of shares (78,355 units at $117.64) as part of a pre-agreed trading plan, decreasing direct ownership by 20% to 214,678 units (SEC Form 4)4 - Twist Bioscience Corp (0001581280) (Issuer)
- SECTwist Bioscience Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Twist Bioscience Corp (0001581280) (Filer)
- SECSEC Form 424B7 filed by Twist Bioscience Corporation424B7 - Twist Bioscience Corp (0001581280) (Filer)
- SECSEC Form SCHEDULE 13G filed by Twist Bioscience CorporationSCHEDULE 13G - Twist Bioscience Corp (0001581280) (Subject)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Twist Bioscience CorporationSCHEDULE 13G/A - Twist Bioscience Corp (0001581280) (Subject)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Twist Bioscience CorporationSCHEDULE 13G/A - Twist Bioscience Corp (0001581280) (Subject)
- INSIDERChief Executive Officer Leproust Emily M. exercised 113,318 shares at a strike of $26.66 and sold $14,183,051 worth of shares (113,318 units at $125.16) as part of a pre-agreed trading plan (SEC Form 4)4 - Twist Bioscience Corp (0001581280) (Issuer)
- SECSEC Form 144 filed by Twist Bioscience Corporation144 - Twist Bioscience Corp (0001581280) (Subject)
- INSIDERDirector Chess Robert sold $2,042,261 worth of shares (18,417 units at $110.89) as part of a pre-agreed trading plan and exercised 18,417 shares at a strike of $11.89 (SEC Form 4)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDEROfficer Cho Dennis sold $1,558,999 worth of shares (14,205 units at $109.75) as part of a pre-agreed trading plan, decreasing direct ownership by 14% to 89,866 units (SEC Form 4)4 - Twist Bioscience Corp (0001581280) (Issuer)
- SECSEC Form 144 filed by Twist Bioscience Corporation144 - Twist Bioscience Corp (0001581280) (Subject)
- SECSEC Form SCHEDULE 13G filed by Twist Bioscience CorporationSCHEDULE 13G - Twist Bioscience Corp (0001581280) (Subject)
- SECTwist Bioscience Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Twist Bioscience Corp (0001581280) (Filer)
- SECSEC Form 424B5 filed by Twist Bioscience Corporation424B5 - Twist Bioscience Corp (0001581280) (Filer)
- INSIDERChief Executive Officer Leproust Emily M. sold $435,223 worth of shares (5,101 units at $85.32), decreasing direct ownership by 0.62% to 818,938 units (SEC Form 4) to satisfy withholding tax4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERSVP of Human Resources Green Paula sold $96,669 worth of shares (1,133 units at $85.32), decreasing direct ownership by 0.94% to 119,281 units (SEC Form 4) to satisfy withholding tax4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERPresident and COO Finn Patrick John sold $246,408 worth of shares (2,888 units at $85.32), decreasing direct ownership by 1% to 269,678 units (SEC Form 4) (withholding obligation)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDEROfficer Cho Dennis sold $91,294 worth of shares (1,070 units at $85.32), decreasing direct ownership by 1% to 104,071 units (SEC Form 4) to satisfy tax liability4 - Twist Bioscience Corp (0001581280) (Issuer)
TWST FAQ
7 questionsWhat does Twist Bioscience Corporation do?
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with ImmunoPrecise Antibodies Ltd.; Victorian Clinical Genetic Services; Vivlion GmbH; and Kyowa Kirin Pharmaceutical Research, Inc. Twist...Where does TWST stock trade?
Twist Bioscience Corporation (TWST) is listed on NASDAQ.What sector and industry is TWST in?
Twist Bioscience Corporation operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.When did Twist Bioscience Corporation go public?
Twist Bioscience Corporation (TWST) completed its IPO in 2018.What are analysts saying about TWST?
Twist Bioscience Corporation has had 8 recent analyst actions on file. The most recent action was from Evercore ISI: In-line on 2026-07-06. Recent price targets range from $2700.00 to $4500.00.What companies are similar to TWST?
Notable peers in the same industry include AMGN (Amgen Inc.), GILD (Gilead Sciences Inc.), MRNA (Moderna Inc.), ARGX (argenx SE), RVMD (Revolution Medicines Inc.). Compare TWST side-by-side with any of them on Quantisnow.How can I track TWST on Quantisnow?
Quantisnow aggregates Twist Bioscience Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow TWST to receive live email and push alerts on every new disclosure.